Trial · NCT00316888
Adverse events250
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 250
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Tinnitus | Ear and labyrinth disorders | Arm I (Closed to Accrual as of 11/3/2008) | 3 | 28 | |
| other | Tinnitus | Ear and labyrinth disorders | Arm II (Open to Accrual on 8/18/2009) | 1 | 34 | |
| other | Anemia | Blood and lymphatic system disorders | Arm I (Closed to Accrual as of 11/3/2008) | 11 | 28 | |
| other | Anemia | Blood and lymphatic system disorders | Arm II (Open to Accrual on 8/18/2009) | 12 | 34 | |
| other | Leukocytes decreased | Investigations | Arm I (Closed to Accrual as of 11/3/2008) | 15 | 28 | |
| other | Leukocytes decreased | Investigations | Arm II (Open to Accrual on 8/18/2009) | 11 | 34 | |
| other | Lymphopenia | Investigations | Arm I (Closed to Accrual as of 11/3/2008) | 2 | 28 | |
| other | Lymphopenia | Investigations | Arm II (Open to Accrual on 8/18/2009) | 1 | 34 | |
| other | Neutrophils decreased | Investigations | Arm I (Closed to Accrual as of 11/3/2008) | 11 | 28 | |
| other | Neutrophils decreased | Investigations | Arm II (Open to Accrual on 8/18/2009) | 7 | 34 | |
| other | Platelets decreased | Investigations | Arm I (Closed to Accrual as of 11/3/2008) | 11 | 28 | |
| other | Platelets decreased | Investigations | Arm II (Open to Accrual on 8/18/2009) | 14 | 34 | |
| other | Sinus tachycardia | Cardiac disorders | Arm I (Closed to Accrual as of 11/3/2008) | 0 | 28 | |
| other | Sinus tachycardia | Cardiac disorders | Arm II (Open to Accrual on 8/18/2009) | 2 | 34 | |
| other | Hypertension | Vascular disorders | Arm I (Closed to Accrual as of 11/3/2008) | 0 | 28 | |
| other | Hypertension | Vascular disorders | Arm II (Open to Accrual on 8/18/2009) | 3 | 34 | |
| other | Hypotension | Vascular disorders | Arm I (Closed to Accrual as of 11/3/2008) | 2 | 28 | |
| other | Hypotension | Vascular disorders | Arm II (Open to Accrual on 8/18/2009) | 2 | 34 | |
| other | Fatigue | General disorders | Arm I (Closed to Accrual as of 11/3/2008) | 23 | 28 | |
| other | Fatigue | General disorders | Arm II (Open to Accrual on 8/18/2009) | 23 | 34 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00316888/events